Form 8-K - Current report:
SEC Accession No. 0001193125-24-255170
Filing Date
2024-11-12
Accepted
2024-11-12 07:45:38
Documents
67
Period of Report
2024-11-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d794017d8k.htm   iXBRL 8-K 25805
2 EX-99.1 d794017dex991.htm EX-99.1 68787
6 GRAPHIC g794017ex99_1p10g1.jpg GRAPHIC 316515
7 GRAPHIC g794017ex99_1p11g1.jpg GRAPHIC 251562
8 GRAPHIC g794017ex99_1p12g1.jpg GRAPHIC 298113
9 GRAPHIC g794017ex99_1p13g1.jpg GRAPHIC 402122
10 GRAPHIC g794017ex99_1p14g1.jpg GRAPHIC 379951
11 GRAPHIC g794017ex99_1p15g1.jpg GRAPHIC 385880
12 GRAPHIC g794017ex99_1p16g1.jpg GRAPHIC 236438
13 GRAPHIC g794017ex99_1p17g1.jpg GRAPHIC 450100
14 GRAPHIC g794017ex99_1p18g1.jpg GRAPHIC 246165
15 GRAPHIC g794017ex99_1p19g1.jpg GRAPHIC 347579
16 GRAPHIC g794017ex99_1p1g1.jpg GRAPHIC 441054
17 GRAPHIC g794017ex99_1p20g1.jpg GRAPHIC 362718
18 GRAPHIC g794017ex99_1p21g1.jpg GRAPHIC 372795
19 GRAPHIC g794017ex99_1p22g1.jpg GRAPHIC 225138
20 GRAPHIC g794017ex99_1p23g1.jpg GRAPHIC 101765
21 GRAPHIC g794017ex99_1p24g1.jpg GRAPHIC 335429
22 GRAPHIC g794017ex99_1p25g1.jpg GRAPHIC 280266
23 GRAPHIC g794017ex99_1p26g1.jpg GRAPHIC 356963
24 GRAPHIC g794017ex99_1p27g1.jpg GRAPHIC 244703
25 GRAPHIC g794017ex99_1p28g1.jpg GRAPHIC 386717
26 GRAPHIC g794017ex99_1p29g1.jpg GRAPHIC 298030
27 GRAPHIC g794017ex99_1p2g1.jpg GRAPHIC 507762
28 GRAPHIC g794017ex99_1p30g1.jpg GRAPHIC 318091
29 GRAPHIC g794017ex99_1p31g1.jpg GRAPHIC 210953
30 GRAPHIC g794017ex99_1p32g1.jpg GRAPHIC 569200
31 GRAPHIC g794017ex99_1p33g1.jpg GRAPHIC 445554
32 GRAPHIC g794017ex99_1p34g1.jpg GRAPHIC 395631
33 GRAPHIC g794017ex99_1p35g1.jpg GRAPHIC 453097
34 GRAPHIC g794017ex99_1p36g1.jpg GRAPHIC 369770
35 GRAPHIC g794017ex99_1p37g1.jpg GRAPHIC 423450
36 GRAPHIC g794017ex99_1p38g1.jpg GRAPHIC 101486
37 GRAPHIC g794017ex99_1p39g1.jpg GRAPHIC 345374
38 GRAPHIC g794017ex99_1p3g1.jpg GRAPHIC 352114
39 GRAPHIC g794017ex99_1p40g1.jpg GRAPHIC 273443
40 GRAPHIC g794017ex99_1p41g1.jpg GRAPHIC 465066
41 GRAPHIC g794017ex99_1p42g1.jpg GRAPHIC 101587
42 GRAPHIC g794017ex99_1p43g1.jpg GRAPHIC 293698
43 GRAPHIC g794017ex99_1p44g1.jpg GRAPHIC 296782
44 GRAPHIC g794017ex99_1p45g1.jpg GRAPHIC 419040
45 GRAPHIC g794017ex99_1p46g1.jpg GRAPHIC 102935
46 GRAPHIC g794017ex99_1p47g1.jpg GRAPHIC 323724
47 GRAPHIC g794017ex99_1p48g1.jpg GRAPHIC 233365
48 GRAPHIC g794017ex99_1p49g1.jpg GRAPHIC 474905
49 GRAPHIC g794017ex99_1p4g1.jpg GRAPHIC 351684
50 GRAPHIC g794017ex99_1p50g1.jpg GRAPHIC 248303
51 GRAPHIC g794017ex99_1p51g1.jpg GRAPHIC 395453
52 GRAPHIC g794017ex99_1p52g1.jpg GRAPHIC 287473
53 GRAPHIC g794017ex99_1p53g1.jpg GRAPHIC 250818
54 GRAPHIC g794017ex99_1p5g1.jpg GRAPHIC 411418
55 GRAPHIC g794017ex99_1p6g1.jpg GRAPHIC 386014
56 GRAPHIC g794017ex99_1p7g1.jpg GRAPHIC 297533
57 GRAPHIC g794017ex99_1p8g1.jpg GRAPHIC 101944
58 GRAPHIC g794017ex99_1p9g1.jpg GRAPHIC 331385
  Complete submission text file 0001193125-24-255170.txt   24022279

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA howl-20241112.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE howl-20241112_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE howl-20241112_pre.xml EX-101.PRE 11714
69 EXTRACTED XBRL INSTANCE DOCUMENT d794017d8k_htm.xml XML 3784
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40366 | Film No.: 241443380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)